ReviewDiabetology & metabolic syndrome2026

Therapeutic potential of GLP-1 receptor agonists and SGLT2 inhibitors in diabetic neuropathy: a critical appraisal.

Dan Ziegler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.